on-the-go breakfast products market Rising urbanization and the prevalence of nuclear families are leading to increased demands on-the-go breakfast products market working women’s time, leaving little room for leisurely breakfasts. Fast-paced lives, longer commutes, and growing female workforce participation are driving the demand for on-the-go breakfast products, with a notable impact in Asia Pacific, North America, …
Category Archives: Press Release
Middle East and North Africa Nutraceuticals Market: Comprehensive Growth Outlook with Revenue Milestone of US$ 1,900 Million by 2026
on-the-go breakfast products market Rising urbanization and the prevalence of nuclear families are leading to increased demands on-the-go breakfast products market working women’s time, leaving little room for leisurely breakfasts. Fast-paced lives, longer commutes, and growing female workforce participation are driving the demand for on-the-go breakfast products, with a notable impact in Asia Pacific, North America, …
Middle East and North Africa Nutraceuticals Market: In-Depth Sector Analysis and Growth Forecast
The MENA nutraceuticals market is expected to display an impressive 7.1% CAGR between 2015 and 2020. According to FMI reports, the current covid-19 pandemic is moderately impacting the MENA nutraceuticals industry, as supplies of products run out, despite high demand for preventive healthcare and dietary supplement products. Sales continue apace as consumers seek nutraceuticals for immune boosting …
Frozen Food Market Forecast: Strategic Industry Analysis Predicts Growth to US$ 638.6 Billion by 2034
According to Future Market Insights (FMI), the global frozen food market is projected to increase from US$ 365.2 billion in 2024 to US$ 638.6 billion by 2034. The market is projected to surge at a CAGR of 5.7% from 2024 to 2034. Due to their convenience of preparation and single-serving alternatives, frozen foods are becoming increasingly popular among consumers, particularly among millennials. The …
Global Progressive Pulmonary Fibrosis (PPF) Treatment Market Set to Flourish, Expected to Reach US$ 7.7 Million by 2033 at a 7.5% CAGR
The global progressive pulmonary fibrosis (PPF) treatments market is anticipated to grow at a compound annual growth rate (CAGR) of 7.5% from 2023 to 2033, with a projected value of US$ 3.72 million in 2023. Future therapy options for idiopathic pulmonary fibrosis appear to include a number of investigational cancer medications. Additionally, major players are putting …
Global CRISPR and Cas Gene Market for Spectacular Growth, Projected to Reach US$ 32.9 Billion by 2033 at a 30.2% of CAGR
The global CRISPR and Cas gene editing Market is expected to generate US$ 1.8 billion in sales by 2021. The anticipated market growth between 2023 and 2033, at 30.2%, is anticipated to be substantially more than the growth observed historically. The biomedical sector is anticipated to generate the most income, with a compound annual growth rate …
Global Chronic Obstructive Pulmonary Disease Industry Poised for Steady Growth at 4.4% CAGR, Reaching US$33.2 Billion by 2033 | FMI
The Global Chronic Obstructive Pulmonary Disease Industry is on track for consistent growth, driven by a rising disease burden. According to Future Market Insights (FMI), the market reached an estimated value of US$21.58 billion in 2023. Looking ahead, it’s projected to climb to US$33.19 billion by 2033, reflecting a Compound Annual Growth Rate (CAGR) of …
Global Hermansky Pudlak Syndrome Therapeutics Market for Explosive Growth, Projected to Reach US$ 12 Billion by 2033 at a 7.2% CAGR
The global Hermansky-Pudlak Syndrome (HPS) therapeutics market was valued at US$ 6 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 7.2% from 2023 to 2033, when it is predicted to reach US$ 12 billion. The development of the global hermansky pudlak syndrome therapeutics market is mostly due to …
Global Human Immunodeficiency Virus Type 1 (HIV-1) Industry is predicted to develop at a consistent 6% CAGR to reach US$ 62 Billion By 2033 | FMI
The fight against HIV/AIDS is reaching a significant milestone, with the Global Human Immunodeficiency Virus Type 1 (HIV-1) Industry projected to reach a remarkable US$34.83 billion in 2023. This noteworthy valuation signifies a turning point in the battle against the disease. Fueled by a compound annual growth rate (CAGR) of 6%, the market is expected …
Global Multiple System Atrophy (MSA) Therapeutics Market Continues Upward Trajectory, Projected to Reach US$ 211.1 Million by 2033 at a 4.4% CAGR
The global Multiple System Atrophy (MSA) therapeutics market is expected to grow at a compound annual growth rate (CAGR) of 4.4%, with a current valuation of US$ 137.3 million by 2023. Healthcare technology advancements are expected to drive the market to US$ 211.1 million by 2033. Multiple system atrophy (MSA) is a neurodegenerative disorder that causes symptoms that …